Drug profile · INN
lutetium lu-177 vipivotide tetraxetan
PLUVICTO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lutetium lu-177 vipivotide tetraxetan (PLUVICTO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN lutetium lu-177 vipivotide tetraxetan
Brand PLUVICTO
Route INTRAVENOUS
Formulation SOLUTION
Frequently asked questions
What is lutetium lu-177 vipivotide tetraxetan?
lutetium lu-177 vipivotide tetraxetan (PLUVICTO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for lutetium lu-177 vipivotide tetraxetan?
PLUVICTO is a marketed brand name for lutetium lu-177 vipivotide tetraxetan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lutetium lu-177 vipivotide tetraxetan?
lutetium lu-177 vipivotide tetraxetan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.